Rubius Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Rubius Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q4 2022.
  • Rubius Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2022 was $2.68M, a 92.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $2.68M -$32.4M -92.4% Dec 31, 2022 10-K 2023-02-27
Q3 2022 $31.2M -$5.09M -14% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $32.5M -$5.18M -13.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $33.8M -$5.26M -13.4% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $35.1M -$5.35M -13.2% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $36.3M -$5.19M -12.5% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $37.7M -$4.98M -11.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $39.1M -$4.89M -11.1% Mar 31, 2021 10-Q/A 2021-08-20
Q4 2020 $40.4M -$6.11M -13.1% Dec 31, 2020 10-K 2023-02-27
Q3 2020 $41.5M -$6.43M -13.4% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $42.7M +$15.1M +54.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $44M +$14.8M +50.8% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $46.6M +$44.8M +2559% Dec 31, 2019 10-K 2022-02-25
Q3 2019 $47.9M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $27.6M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $29.2M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $1.75M Jan 1, 2019 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.